AAM
TXG icon

Advisors Asset Management’s 10x Genomics TXG Stock Holding History

Advisors Asset Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,368
Closed -$133K – 1499
2025
Q3 		$133K Sell
11,368
-175
-2% -$2.28K ﹤0.01% 1184
2025
Q2 		$134K Sell
11,543
-13,237
-53% -$121K ﹤0.01% 1165
2025
Q1 		$216K Sell
24,780
-805
-3% -$10.1K ﹤0.01% 1098
2024
Q4 		$367K Sell
25,585
-1,232
-5% -$19.4K 0.01% 995
2024
Q3 		$606K Sell
26,817
-674
-2% -$13.9K 0.01% 871
2024
Q2 		$535K Buy
27,491
+2,263
+9% +$59.3K 0.01% 875
2024
Q1 		$947K Buy
25,228
+5,406
+27% +$238K 0.02% 752
2023
Q4 		$1.11M Buy
19,822
+9,357
+89% +$407K 0.02% 699
2023
Q3 		$432K Buy
10,465
+2,903
+38% +$151K 0.01% 936
2023
Q2 		$422K Buy
7,562
+562
+8% +$30.4K 0.01% 979
2023
Q1 		$391K Sell
7,000
-750
-10% -$35K 0.01% 987
2022
Q4 		$282K Sell
7,750
-11,549
-60% -$378K 0.01% 1073
2022
Q3 		$550K Sell
19,299
-1,143
-6% -$43.5K 0.01% 906
2022
Q2 		$925K Sell
20,442
-573
-3% -$29.7K 0.02% 781
2022
Q1 		$1.6M Sell
21,015
-874
-4% -$76.5K 0.02% 659
2021
Q4 		$3.26M Buy
21,889
+2,435
+13% +$373K 0.05% 446
2021
Q3 		$2.83M Buy
19,454
+3,847
+25% +$660K 0.04% 465
2021
Q2 		$3.06M Buy
15,607
+4,922
+46% +$891K 0.05% 449
2021
Q1 		$1.93M Buy
10,685
+6,134
+135% +$1.06M 0.03% 606
2020
Q4 		$644K Buy
+4,551
New +$660K 0.01% 899

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisors Asset Management's TXG Position: Q4 2025 in Review

Advisors Asset Management sold out of 10x Genomics (TXG) in Q4 2025, closing a stake of 11,368 shares — an estimated $133K sold.

Advisors Asset Management first reported a position in TXG in Q4 2020 and held it in 20 quarters. The position peaked at $3.26M in Q4 2021. 322 funds tracked by Wall St. Rank hold TXG as of Q4 2025.

  • Advisors Asset Management reported no remaining 10x Genomics position as of Q4 2025 after selling out during the quarter.
  • Advisors Asset Management sold 11,368 10x Genomics shares in Q4 2025, an estimated $133K.
  • Advisors Asset Management first reported a position in 10x Genomics in Q4 2020 and held it in 20 quarters.
  • Advisors Asset Management's 10x Genomics position peaked at $3.26M in Q4 2021.
  • 322 funds tracked by Wall St. Rank held 10x Genomics as of Q4 2025.

Based on Advisors Asset Management's 13F filing for Q4 2025, filed 12 Feb 2026.